Beacon Investment Advisory Services, Inc. Portage Biotech Inc. Transaction History

Beacon Investment Advisory Services, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.09 - $2.65 $12,420 - $30,196	11,395 New	11,395 $20,000
Q2 2022 Jul 21, 2022	BUY	$5.16 - $11.95 $58,798 - $136,170	11,395 New	11,395 $80,000
Q1 2022 May 12, 2022	SELL	$6.57 - $12.0 $74,865 - $136,740	-11,395 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$10.73 - $23.74 $122,268 - $270,517	11,395 New	11,395 $122,000
Q2 2021 Aug 02, 2021	SELL	$20.96 - $42.81 $238,839 - $487,819	-11,395 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$17.55 - $39.5 $199,982 - $450,102	11,395 New	11,395 $319,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $83M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.